ProCE Banner Activity

Expert Review of Treatment for HER2-Negative Early Breast Cancer

Slideset

Download these slides for an in-depth review of treatment for HER2-negative early breast cancer.

Released: August 31, 2023

Share

Faculty

Kevin Kalinsky

Kevin Kalinsky, MD, MS

Director, Glenn Family Breast Center
Hematology and Medical Oncology
Winship Cancer Institute
Emory University
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC in partnership with Smart Patients.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

Smart Patients

ProCE Banner